Utilization of material containing docosapentaenoic acid
    1.
    发明授权
    Utilization of material containing docosapentaenoic acid 有权
    含有二十碳五烯酸的材料的利用

    公开(公告)号:US06596766B1

    公开(公告)日:2003-07-22

    申请号:US09914897

    申请日:2002-01-17

    IPC分类号: A61K3120

    摘要: A novel technique for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo. Utilizaiton of a DPA-containing material for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo; and compositions for relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo which contain a DPA-containing material in an amount efficacious in relieving arachidonic acid deficient conditions and maintaining a good fatty acid balance in vivo per unit dose.

    摘要翻译: 一种减轻花生四烯酸缺乏条件并保持体内良好脂肪酸平衡的新技术。 用于减少花生四烯酸缺乏条件并维持体内良好的脂肪酸平衡的含DPA的材料; 以及用于缓解花生四烯酸缺乏条件并保持体内良好脂肪酸平衡的组合物,其含有含量为DPA的材料,其量有效地缓解了花生四烯酸缺乏条件并维持每单位剂量的体内良好的脂肪酸平衡。

    Agent for improving physiological motor functions
    4.
    发明申请
    Agent for improving physiological motor functions 审中-公开
    改善生理运动功能的药剂

    公开(公告)号:US20070099853A1

    公开(公告)日:2007-05-03

    申请号:US10561171

    申请日:2004-05-14

    IPC分类号: A61K31/7048 A61K31/353

    CPC分类号: A61K31/352 A23L33/105

    摘要: The present invention provides an agent for improving physiological motor functions which is characterized in containing proanthocyanidin as an effective ingredient. It is useful as an agent for preventing and improving the fatigue in which rise in lactic cid value upon physical exercise is suppressed whereby muscular fatigue is reduced and continuous exercise is made easy, and particularly as an agent for prevention and improvement of muscular fatigue, and as a health food for prevention and improvement of fatigue.

    摘要翻译: 本发明提供一种改善生理运动功能的药剂,其特征在于含有原花色素作为有效成分。 作为用于预防和改善体育锻炼时乳酸值上升被抑制从而减轻肌肉疲劳并使连续运动变得容易的疲劳的作用剂,特别是作为预防和改善肌肉疲劳的药剂是有用的,以及 作为预防和改善疲劳的保健食品。

    Skin Moisturizer
    5.
    发明申请
    Skin Moisturizer 审中-公开
    皮肤保湿

    公开(公告)号:US20080020067A1

    公开(公告)日:2008-01-24

    申请号:US10594900

    申请日:2005-03-31

    IPC分类号: A61K36/31 A61Q19/00

    摘要: The present invention provides an oral skin moisturizer that is readily available to those who are suffering from dry skin, has no side effects, and when orally ingested, enhances the moisture-retaining ability of the skin. The invention also provides food products or the like that contain the oral skin moisturizer. Specifically, the oral skin moisturizer contains, as an active ingredient, a extract of a plant of the genus Lepidium of the family Cruciferae. More specifically, the oral skin moisturizer contains as an active ingredient a extract of maca (Lepidium meyenii Walp). Food products, liquors, functional food products, and pharmaceutical products containing the oral skin moisturizer are also provided.

    摘要翻译: 本发明提供一种口服皮肤保湿剂,其对于患有干性皮肤的患者容易获得,没有副作用,并且当口服摄取时,增强皮肤的保湿能力。 本发明还提供含有口腔保湿剂的食品等。 具体而言,口腔保湿剂含有十字花科植物的植物提取物作为活性成分。 更具体地,口腔保湿剂含有作为活性成分的马卡提取物(Lepidium meyenii Walp)。 还提供食品,酒,功能性食品和含有口腔保湿剂的药物。

    Peripheral Blood Flow-Improving Composition
    8.
    发明申请
    Peripheral Blood Flow-Improving Composition 审中-公开
    外周血流改善组合

    公开(公告)号:US20080260874A1

    公开(公告)日:2008-10-23

    申请号:US10594905

    申请日:2005-03-31

    IPC分类号: A61K36/31 A61P7/00

    摘要: The present invention provides a composition that can effectively improve peripheral blood flow to thereby ameliorate cold sensation, numbness, pains and other skin symptoms, as well as frostbites, chilblains and chaps and other skin disorders associated with disturbed peripheral blood flow. This composition has no side effects. Specifically, the peripheral blood flow-improving composition contains, as an active ingredient, a extract of a plant of the genus Lepidium of the family Cruciferae. More specifically, the composition contains as an active ingredient a extract of maca plant (Lepidium meyenii Walp). Food and beverage products, perfumes and cosmetics, and pharmaceutical products containing the peripheral blood flow-improving composition are also provided.

    摘要翻译: 本发明提供一种组合物,其可以有效地改善外周血流量,从而改善冷感,麻木,疼痛和其它皮肤症状,以及与受干扰的外周血流相关的冻伤,冷冻和裂纹和其它皮肤病症。 该组合物没有副作用。 具体而言,外周血流量改善组合物含有十字花科植物的植物提取物作为活性成分。 更具体地,该组合物含有作为活性成分的马卡植物提取物(Lepidium meyenii Walp)。 还提供食品和饮料产品,香水和化妆品以及含有外周血液流动改善组合物的药物。

    Compositions normalizing circadian rhythm
    9.
    发明授权
    Compositions normalizing circadian rhythm 有权
    组合使昼夜节律正常化

    公开(公告)号:US07001611B2

    公开(公告)日:2006-02-21

    申请号:US10030715

    申请日:2001-05-15

    CPC分类号: A61K31/122

    摘要: The present invention provides a circadian rhythm normalizing composition containing astaxanthin and/or its ester as an active ingredient, and a composition having the action of enhancing the circadian rhythm normalizing action of melatonin by protecting melatonin. The composition can be in the form of a drug, a functional food, a food or a beverage.This composition has a circadian rhythm normalizing action, and has the action of preventing or alleviating sleep disorder and various diseases due to disturbance of the circadian rhythm.

    摘要翻译: 本发明提供含有虾青素和/或其酯作为活性成分的昼夜节律标准化组合物,以及具有通过保护褪黑激素增强褪黑激素的昼夜节律正常化作用的作用的组合物。 组合物可以是药物,功能食品,食品或饮料的形式。

    Remedies for hyperammonemia
    10.
    发明授权
    Remedies for hyperammonemia 失效
    高氨血症的补救措施

    公开(公告)号:US06852707B1

    公开(公告)日:2005-02-08

    申请号:US09857695

    申请日:1999-12-09

    摘要: By using xylobiose or xylooligosaccharide containing xylobiose as a main ingredient in place of lactulose, there is provided a blood ammonia lowering agent, a therapeutic agent of hyperammonemia or a therapeutic agent of hepatic encephalopathy that need be adminstered in smaller doses and which have no concern over side effects.Lactulose conventionally used as such drugs has to be administered in high doses and involves a safety problem when administered to patients with galactosemia or diabetes mellitus. The drug of the invention which contains xylobiose as a main ingredient solves these problems.

    摘要翻译: 通过使用含有木二糖的木二糖或低聚木糖作为主要成分代替乳果糖,提供了血氨降解剂,高氨血症治疗剂或肝性脑病治疗剂,其需要以较小剂量施用且不关心 常规使用的乳糖苷必须以高剂量施用,并且当给予患有半乳糖血症或糖尿病的患者时涉及安全问题。 含有木二糖作为主要成分的本发明药物解决了这些问题。